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Abstract
Lymphocytic esophagitis is a new and rare entity, first described in 2006. Histologically, the 
esophageal mucosa is characterized by a dense peripapillary lymphocytic infiltrate and an 
intercellular edema without granulocytosis. To this day, it is not yet considered as a disease. 
Its etiology and clinical significance are still unclear. The predominant symptom is dyspha-
gia and the main endoscopic feature is a normal esophagus. The absence of relationship 
between lymphocytic esophagitis and specific clinical conditions justifies further studies. 
Currently, it remains a histologic entity.
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1. Introduction
Lymphocytic esophagitis is a histopathological entity described for the first time in 2006 by 
Rubio et al. [1]. Subsequently, several publications have confirmed the existence of this new 
condition. Research has allowed us to better characterize the histology of Lymphocytic esoph-
agitis. Unfortunately, clinical presentation and treatment remain poorly understood.
2. Prevalence
Lymphocytic esophagitis is a very rare condition. In 2012, Haque et al. estimated its preva-
lence to 0.1% in the United States [2]. In their cohort that included 129,252 esophageal biop-
sies, a diagnosis of lymphocytic esophagitis was made in only 119 patients. Since Rubio’s first 
publication, there is a marked increase of its incidence, probably because of pathologists’ and 
gastroenterologists’ awareness [3].
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
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Moreover, since it is a novel entity and most of the studies are from North America, world-
wide prevalence has not been evaluated.
3. Histology
A small amount of intraepithelial lymphocytes is normally present in the esophagus [4, 5]. 
A majority of these lymphocytes are CD8 T cells, whereas CD4 are a minority and usually 
present in the lamina propria. An increase in CD8 T cells is seen in peptic and eosinophilic 
esophagitis. In addition, this lymphocytosis is generally accompanied by eosinophils and/or 
neutrophils [5–8].
Compared to other esophageal pathologies, lymphocytic esophagitis is characterized by an 
isolated lymphocytosis. The main histologic findings are a dense peripapillary intraepithelial 
lymphocytic infiltrate, an intercellular edema known as spongiosis, as well as the absence or 
rarity of granulocytes (Figure 1) [1]. The intraepithelial lymphocytes express CD3, CD4, and 
CD8, as shown by immunohistochemistry [1, 9, 11].
Unfortunately, because the histologic criteria are not yet standardized, it can sometimes lead 
to misdiagnosis. For instance, the presence of rare intraepithelial granulocytes is accepted in 
lymphocytic esophagitis [1, 2, 10, 11]. However, granulocytes can be found in various esopha-
geal diseases, making diagnosis more difficult [11]. The acceptable number of granulocytes 
still needs to be better defined.
Figure 1. Lymphocytic esophagitic (H&E stain, original magnification ×40). Dense peripapillary lymphocytic infiltrate 
with spongiosis (arrow). Absence of neutrophils and eosinophils.
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Because the lymphocytosis is patchy and uneven, we suggest not to establish a minimum 
number of intraepithelial lymphocytes [2]. In fact, the various studies about this entity have 
all used different cutoff, ranging between 10 and 50 lymphocytes per high-power field (HPF) 
[2, 3, 12, 13].
Furthermore, lymphocytic esophagitis affects the whole esophagus, but predominantly 
the distal esophagus. Thus, multiple biopsies are necessary to avoid a false negative 
because the lymphocyte infiltrates are not distributed evenly throughout the entire esoph-
agus [12].
The mucosal involvement is considered mild if the intraepithelial lymphocytosis is only peri-
papillary and is severe if there is also an interperipapillary lymphocyte infiltration [12].
4. Clinical manifestations
Lymphocytic esophagitis seems to affect mostly women around 60 years old and smokers 
[2, 3, 10, 11]. The most common symptom is dysphagia [2, 8, 11, 13]. Nausea, vomiting, chest 
pain, heartburn, and episodes of impactions have also been reported; however, dysphagia 
remains the principal and most frequent complaint in 53% of cases [2, 3, 12]. Patients with 
lymphocytic esophagitis do not appear to show weight loss or fever.
The most serious complication is esophageal perforation. In 10 years, two cases of perfora-
tion have been reported. One of the two perforations occurred after the removal of a piece of 
impacted meat, while the second case was a spontaneous microperforation [14, 15].
5. Endoscopic features
Endoscopically, the most frequent findings are a normal esophagus or esophagitis [2, 3, 11]. 
Up to 33% of cases from the cohort by Haque et al. had findings suspicious of eosinophilic 
esophagitis such as stricture, rings, or felinization without eosinophilic esophagitis on the 
biopsies [2]. As described later, no other gastrointestinal involvement or association with gas-
tritis or duodenitis has been described, thus stomach and duodenum endoscopic appearance 
is normal [12].
The endoscopic features are variable and not specific, which makes it impossible to identify 
and diagnose lymphocytic esophagitis by only relying on symptoms and gastroscopy. It is 
still a histologic condition, which is why biopsy is essential for the diagnosis.
6. Clinical associations
Some retrospective studies and case reports have tried to identify an association between 
lymphocytic esophagitis and other clinical conditions. Whether it was inflammatory 
Lymphocytic Esophagitis
http://dx.doi.org/10.5772/intechopen.69445
165
bowel disease, gastroesophageal reflux disease, celiac disease, asthma, allergies, irritants, 
or connective tissue diseases (lupus, Behçet’s disease), no relationship could be identified 
[2, 11–13, 16].
Lymphocytic esophagitis is isolated to the esophagus. It does not coexist with other digestive 
lymphocytosis such as lymphocytic colitis or lymphocytic gastritis. There is no correlation 
between these distinct entities. In a case series from Purdy et al., some patients had concomi-
tant biopsies from the rest of the digestive tract (stomach, small intestine, or colon). The his-
tologic findings in these biopsies were various and secondary to preexisting conditions. No 
lymphocytic entity was observed in the rest of the gastrointestinal tract [8].
6.1. Gastroesophageal reflux disease
One of the main research efforts was to identify a relationship between lymphocytic esoph-
agitis and reflux. Unfortunately, no association has been established between these two 
conditions [2, 12]. Indeed, only 22 out of 119 patients in the cohort from Haque et al. had 
gastroesophageal reflux disease [2].
6.2. Crohn’s disease
In the cohort from Rubio et al., 8 of 20 patients had Crohn's disease [1]. However, subse-
quent studies failed to replicate this association with inflammatory bowel disease [2, 11, 17]. 
Nevertheless, while it appears that it is not associated with inflammatory bowel disease in 
adults, lymphocytic esophagitis may be a manifestation of upper gastrointestinal Crohn's dis-
ease in the pediatric population [1, 12, 10]. Indeed, seven out of eight Crohn’s disease patients 
from Rubio et al. were pediatric cases. Purdy et al. confirmed this association with the pediat-
ric Crohn’s disease [1].
6.3. Eosinophilic esophagitis
Eosinophilic esophagitis has also been a subject of study and comparison with  lymphocytic 
 esophagitis. The clinical and endoscopic manifestations of lymphocytic esophagitis can 
be  confused with those of eosinophilic esophagitis. It is only histology that allows us to 
 differentiate these two entities. Felinization is not pathognomonic of eosinophilic esophagitis, 
hence the importance of biopsy [2].
In a recent cohort from Rubio et al., out of 311 biopsies with an increased number of intraepi-
thelial lymphocytes, 33 cases were a compound of lymphocytic esophagitis and eosinophilic 
 esophagitis [9]. We can thus ask whether these are two distinct conditions or whether one is 
the continuum of the other. However, this assumption remains a hypothesis and requires to be 
studied.
6.4. Motility disorders
Since 2014, an interest for esophageal motility disorders in lymphocytic esophagitis has arisen. 
Recent studies have demonstrated an association with achalasia and primary esophageal motility 
disorder (nutcracker esophagus, ineffective esophageal motility, and diffuse spasm) [18].
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In 2015, Xue et al. noticed that esophageal biopsies in patients with primary esophageal motil-
ity abnormalities had CD4 + intraepithelial lymphocytosis. Moreover, Xue evoked the pos-
sibility of a new clinical entity that they called “dysmotility-associated LE.” We still need 
further studies to better understand and characterize this association [11].
7. Treatment
Treatment of lymphocytic esophagitis remains controversial. Very few studies addressed this 
subject. Because it is still a recent and rare entity, a majority of therapeutic trials have been 
reported in the form of case reports or retrospective studies.
Proton pump inhibitor, topical or oral steroids as well as esophageal dilation or injections 
of Botox have been tried. All these treatments have been partially effective [3, 13–16, 19–21]. 
Nevertheless, it is too early to establish which treatment is better and should be recommended.
The use of proton pump inhibitor is based on the belief that lymphocytic esophagitis may be 
associated with esophageal reflux. However, as mentioned earlier, this association remains 
unclear and unlikely. Nevertheless, given the low toxicity of proton pump inhibitors, we sug-
gest using them as first line of treatment.
Concerning the efficacy of corticosteroids, it may suggest that lymphocytic and eosinophilic 
esophagitis belong to the same family.
8. Natural history
Unfortunately, we have very little data on the clinical course of this condition. Cohen et al. 
was the only one who studied this sphere through a survey he sent to 29 patients with lym-
phocytic esophagitis. In his cohort, patients report an improvement in their symptoms with 
medical treatment (proton pump inhibitor or anti-TNF for Crohn's cases). Control endosco-
pies were performed in 22 out of 29 patients and 9 esophageal biopsies showed persistence of 
lymphocytic esophagitis despite treatment [3].
Current available literature points out that lymphocytic esophagitis is a chronic condition 
[12]. The risk of esophageal neoplasia is still unknown.
9. Conclusion
Lymphocytic esophagitis is a newly described clinical and histologic condition that will prob-
ably be increasingly recognized upon the next years. Recent publications have allowed us to 
establish clear criteria, thus facilitating the diagnosis. Clinicians need to be aware of this entity 
because lymphocytic esophagitis may eventually be in the diagnostic algorithm of dysphagia.
Pathologists are increasingly recognizing this condition, which is an asset for research. With 
larger cohorts, we will be able to further characterize its worldwide epidemiology, clinical 
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associations, as well as treatment and natural history. Single-cell analysis of the intraepithelial 
lymphocyte subtypes may help in understanding the pathophysiology of the condition and 
compare subgroups with compound eosinophilic esophagitis and those without. As Haque 
once said, “it is a condition in search of a disease.”
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